Pulmonary complications in immunocompromised (IC) patients
Objectives
- Study of infectious complications in immunocompromised patients
- Role of fiberoptic bronchoscopy in lung infections in IC patients
- Study of late noninfectious complications in patients with hematopoietic precursor-cell transplants (HPT)
Projects in Progress
- Utility of early bronchoscopy in the study of pulmonary complications in IS patients
- Role of the determination of galactomannan antigen in bronchoalveolar lavage fluid
Milestones Achieved
- Identification of factors for the prognosis of pulmonary complications in IC patients
- Utility of endoscopic techniques in pulmonary complications in IC patients
Future Challenges
- Identification of new biomarkers in infectious complications in IC patients
- Study of pathogenic mechanisms of post-HPT obliterating bronchiolitis
Publications
Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates
Rañó A, Agustí C, Benito N, Rovira M, Angrill J, Pumarola T, Torres A
Chest 2002; 122: 253-261
Pulmonary infiltrates in non-HIV immunocompromised patients. A diagnostic approach using non-invasive and bronchoscopic techniques
Rañó A, Agustí C, Jimenez P, Angrill J, De Benito N, Danés C, González J, Rovira M, Pumarola T, Moreno A, Torres A
Thorax 2001; 56: 379-387
Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients
Agustí C, Rañó A, Rovira M, Filella X, Benito N, Moreno A, Torres A.
Thorax 2004; 59: 1081-1088
Lines list
- Alfa 1 antitripsina
- Animal Model
- ARDS-ALI
- Community-Acquired Pneumonia (CAP)
- Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
- Lung Cancer
- Networks, European Projects and Collaborations
- Noninvasive Ventilation (NIV)
- Pulmonary complications in immunocompromised (IC) patients
- Ventilator-Associated Pneumonia (VAP)



